From application‐first to science‐first: A two‐phase validation framework for complex <i>in vitro</i> <scp>NAMs</scp>
Validation of new approach methodologies increasingly requires developers to define a context of use (CoU) before establishing scientific credibility, constraining complex in vitro models. This CoU first strategy can impose a structural limitation on validation. We propose a two-phase framework that separates scientific validation from context-specific qualification, bridged by a shared data repository. Under this structure, the model's scientific capabilities and limitations inform the range of potential applications, rather than being constricted to the first CoU selected.
Authors
- Paul Locke
- Yiguang Zhu (ORCID: https://orcid.org/0000-0002-7954-9105)
Institutions
- Johns Hopkins University (US)
Publication Details
- Journal
- Clinical Pharmacology & Therapeutics
- Published
- 2026-08-03
- DOI
- https://doi.org/10.1002/cpt.70428
- Primary Topic
- 3D Printing in Biomedical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00